Japan Tobacco Inc. (JAPAF)
OTC PINK OTC PINK Primary Summary
Japan Tobacco: A 'Buy' On Beat & Raise Quarter, Profitability Outlook
I stick to a "Buy" rating for Japan Tobacco after analyzing its prospects for the short-term and medium-term. JAPAY's 3Q25 adjusted operating profit jumped 30% YoY, thanks to price hikes and higher volumes. The company is anticipating a 24% rise in operating earnings for the full year; it still has plans for additional pricing adjustments.
Japan Tobacco: Staying Positive On New Product And Non-Core Disposal
Japan Tobacco continues to deserve a Buy rating, taking into consideration recent corporate developments. The sale of its non-core pharmaceutical business should lead to a narrowing of the holding company valuation discount and more generous cash distributions. JAPAY is also introducing its latest heated tobacco device and new high-end tobacco stick brand in July this year.
Japan Tobacco: Enjoy The Income While Waiting For Growth
Japan Tobacco offers a high 5% dividend yield, ideal for income-focused investors, despite inconsistent annual dividend growth. The stock has appreciated by 7% annually over five years, with total returns of 12% including dividends. Though no growth is expected this year, future dividend growth is expected as the company aims for high single-digit earnings growth.
Japan Tobacco Inc. (JAPAF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Japan Tobacco Inc. ever had a stock split?
Japan Tobacco Inc. Profile
| Tobacco Industry | Consumer Staples Sector | Mr. Masamichi Terabatake CEO | OTC PINK Exchange | JP3726800000 ISIN |
| JP Country | 53,593 Employees | 31 Dec 2025 Last Dividend | 27 Jun 2012 Last Split | - IPO Date |
Overview
Japan Tobacco Inc., established in 1985 and headquartered in Tokyo, Japan, is a diversified company engaged in the manufacturing and sale of tobacco products, pharmaceuticals, and processed foods both locally and internationally. The company operates under three major segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business, catering to varied customer needs across different markets. With a focus on both traditional and reduced-risk products, Japan Tobacco Inc. is committed to innovation and quality across its diverse product portfolio.
Products and Services
- Tobacco Products:
The company offers a wide range of tobacco products including cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco, cigars, pipes, smokeless tobacco, hookah, and kretek products. Among these, it also provides reduced-risk alternatives like infused tobacco capsules and heated tobacco sticks. These products are marketed under popular brands such as Winston, Camel, MEVIUS, and LD.
- Pharmaceuticals:
In the pharmaceutical segment, Japan Tobacco Inc. is involved in the research, development, manufacture, and sale of prescription drugs. Their pharmaceutical offerings focus on therapeutic areas including cardiovascular, kidney and metabolism related diseases, immunity and inflammation, and disorders of the central nervous system. Through rigorous research and development, the company aims to contribute to medical advancements and healthcare solutions.
- Processed Foods:
The processed food business of Japan Tobacco Inc. includes a diverse range of products like frozen udon noodles, packed rice, frozen okonomiyaki (Japanese savory pancakes), bakery products, and various seasonings such as yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. These products are designed to offer convenience and quality to consumers, enriching their food experiences with traditional and innovative flavors.
Contact Information
